Related Experiment Video
Updated: Jul 18, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
Published on: July 14, 2021
Left ventricular remodeling of hypertrophic cardiomyopathy: longitudinal observation in rural community
Hiroaki Kitaoka1, Toru Kubo, Makoto Okawa
1Cardiology Division, Department of Medicine and Geriatrics, Kochi Medical School, Nankoku-shi, Kochi, Japan.
Insights
Hypertrophic cardiomyopathy (HCM) in rural Japan shows a benign course, but heart failure deaths increase after 10 years. Left ventricular remodeling is a key factor in long-term outcomes for HCM patients.
Area of Science:
- Cardiology
- Clinical Medicine
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
- Understanding the long-term clinical course of HCM is crucial for patient management.
- Rural cohorts may present unique epidemiological characteristics.
Purpose of the Study:
- To assess the long-term clinical course of hypertrophic cardiomyopathy (HCM) in a rural Japanese population.
- To identify causes of mortality and long-term outcomes in this cohort.
- To compare findings with existing data from developed regions.
Main Methods:
- Retrospective analysis of 137 consecutive HCM patients in a rural Japanese cohort.
- Long-term follow-up averaging 11.4 years.
- Analysis of mortality causes, survival rates, and echocardiographic data.
Main Results:
- Overall 5-, 10-, and 15-year survival rates were 91%, 88%, and 79%.
- Sudden death predominated early, while heart failure deaths increased after 10 years.
- End-stage HCM developed in 13% of patients, with 8 deaths from refractory heart failure, often linked to initial LV remodeling.
Conclusions:
- HCM patients in this rural Japanese cohort exhibit a relatively benign long-term course, comparable to developed regions.
- Heart failure mortality due to left ventricular (LV) remodeling becomes as significant as sudden death after 10 years of follow-up.
- Early identification of LV remodeling indicators may aid in predicting severe outcomes.
Background:
The purpose of the present study was to assess the clinical long-term course of hypertrophic cardiomyopathy (HCM) in a rural Japanese cohort.
Methods And Results:
A total of 137 consecutive HCM patients (mean age at diagnosis: 52+/-13 years) were enrolled. During a follow-up period of 11.4+/-5.7 years, 28 patients died of HCM-related causes. Eleven patients died suddenly, 10 died of progressive heart failure, 6 died of stroke associated with atrial fibrillation and 1 died of a postoperative complication of alcohol septal ablation. For the overall study group, 5-, 10- and 15-year cumulative survival rates were 91%, 88% and 79%, respectively. Although sudden death was the predominant cause of HCM-related death during the follow-up period of <10 years, heart failure death increased after follow-up period of >10 years. Fifteen (13%) of 114 patients who had follow-up echocardiography became ;end-stage' HCM and 8 patients died of severe and refractory heart failure. They already showed minimally dilated left ventricular (LV) dimension and lower LV fractional shortening at initial evaluation.
Conclusions:
Although HCM patients in a Japanese rural community showed relatively benign clinical course (the same as cohorts in the developed world), heart failure death because of LV remodeling became equally important to sudden death when they were followed for more than 10 years.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
